enGene Alternatives & Competitors

11 companies similar to enGene — Pioneering mucosal immunotherapy to combat chronic diseases and regenerate insul...

TransCode Therapeutics, Inc.

Delivering a cancer-free future

11 Post-IPO Equity $28.05M

Newton, United States

Biotechnology Health Care +1

Upstream Bio

Developing treatments for inflammatory diseases

78 IPO $693.00M

Waltham, United States

Biotechnology Health Care +2

Affinia Therapeutics

Building the next generation of gene therapies

34 Series C $210.00M

Waltham, United States

Biotechnology Health Care +2

MetiMedi Co., Ltd.

MetiMedi is developing a first-in-class oral immunotherapeutic small molecule in Phase 2 f...

Korea South

Biotechnology Health Care

Track all enGene competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Homology Medicines

Dedicated to addressing the root cause of rare genetic diseases and promising hope for pat...

Post-IPO Equity $187.00M

Biotechnology Health Care

克睿基因 Cure Genetics

Benifiting Lives with Genetic Engineering

15 Series B $95.50M

China

Biotechnology Health Care

Gennao Bio

A genetic medicines company developing first-in-class, targeted nucleic acid therapeutics

5 Series A

Hopewell, United States

Biotechnology Health Care +1

Omniox Inc

Omniox, a biotechnology company, commercializes technologies used in identifying and treat...

1 $20.10M

San Francisco, United Sta...

Biotechnology Health Care +1

NimBio

Enabling Remote Care for Immune-Mediated Diseases

7 Pre-Seed $880.00K

Biotechnology Health Care

Full Circles Therapeutics Inc.

Genome Engineering Comes Full Circle. Harnessing revolutionary, virus-free, technology fo...

4 Venture round

Cambridge, United States

Biotechnology Health Care

Tubulis GmbH

Reimagining ADCs.

73 Acquired $3.66B

Germany

Biotechnology Health Care +3

About enGene

enGene is a biotechnology startup pioneering mucosal immunotherapy to combat chronic diseases and regenerate insulin secretion for diabetes management. Established in 1999, the company focuses on developing a mucosal immunotherapy platform to target inflammatory bowel disease and diabetes. It features a versatile nucle...

Business keywords

Mucosal Immunotherapy, Inflammatory Bowel Disease, Diabetes Management, Nucleotide Delivery Technology, Chronic Diseases Treatment, Protein Expression Modulation, Insulin Secretion Regeneration, Gene Therapy, Urology, Oncology, Immunotherapy, Bladder Cancer, DNA, RNA, Genetic Medicines

Frequently Asked Questions

Companies similar to enGene include TransCode Therapeutics, Inc., Upstream Bio, Affinia Therapeutics, MetiMedi Co., Ltd., Homology Medicines. They work in Biotechnology and Health Care and share enGene's focus on gene therapy, immunotherapy and genetic medicines.

Bounce Watch lists 11 companies that share enGene's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches enGene and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

enGene Profile TransCode Therapeutics, Inc. Alternatives Upstream Bio Alternatives Affinia Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at enGene on 26 Jul 2024. The 11 companies listed here were last checked between 12 Sep 2024 and 30 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.